GSK
Taking advantage of new kinds of neural network models to accelerate drug discovery
"The Cerebras CS-3 is a critical component that allows GSK to train language models using biological datasets at a scale and size previously unattainable. These foundational models form the basis of many of our AI systems and play a vital role in the discovery of transformational medicines."
Kim Branson
SVP Global Head of AI and ML @ GSK
Kim Branson, SVP Global Head of AI and ML at GSK, discusses AI for drug discovery and the Cerebras partnership
